Search results for "Roth"

showing 10 items of 806 documents

Distal spleno-renal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding

1992

Meta-analysis was used to evaluate 4 clinical trials comparing distal spleno-renal shunt (DSRS) with endoscopic sclerotherapy (EVS) in the prevention of variceal rebleeding: the interval between bleeding and therapy ranges from 100 days. A questionnaire was sent to each author of the published trials concerning methods, definitions and results of the trials in order to obtain more detailed and up-to-date information. The selected end-points for the meta-analysis were: rebleeding, mortality and chronic encephalopathy. Analysis of the results in the questionnaires was made using the method proposed by Collins. The pooled relative risk (i.e. the combined Odds ratio of each trial as an estimate…

medicine.medical_specialtyHepatologybusiness.industrymedicine.medical_treatmentOdds ratiomedicine.diseaseGastroenterologyConfidence intervallaw.inventionClinical trialRandomized controlled triallawInternal medicineRelative riskmedicineSclerotherapyPortal hypertensionbusinessVaricesJournal of Hepatology
researchProduct

Systematic search for neutropenia should be part of the first screening in patients with poikiloderma.

2011

Poikiloderma occurs in a number of hereditary syndromes, the best known of which is Rothmund-Thomson syndrome (RTS). Differential diagnoses include Dyskeratosis Congenita (DC) with high genetic heterogeneity and Clericuzio-type Poikiloderma with Neutropenia (CPN) due to mutations in the C16orf57 gene. Mutations in the RECQL4 gene are only observed in two thirds of RTS patients. In this study, 10 patients referred for syndromic poikiloderma and negative for RECQL4 sequencing analysis were investigated for C16orf57 mutations. Two C16orf57 heterozygous nonsense mutations (p.W81X and p.Y89X) were identified in a 5-year-old female child presenting with generalized poikiloderma, dental dysplasia,…

medicine.medical_specialtyHeterozygoteNeutropeniaNonsense mutationPoikilodermaNeutropeniaDiagnosis DifferentialGeneticsmedicineHumansAbnormalities MultipleGenetic TestingGenetics (clinical)Genetic testingRetrospective StudiesGeneticsmedicine.diagnostic_testRecQ HelicasesGenetic heterogeneitybusiness.industryRothmund-Thomson SyndromeGeneral Medicinemedicine.diseaseDermatologyPedigreePalmoplantar keratodermaCodon NonsenseChild PreschoolAbsolute neutrophil countErythrocyte CountFemalebusinessDyskeratosis congenitaEuropean journal of medical genetics
researchProduct

In vivo inhibition of AChE activity in the European eel Anguilla anguilla exposed to technical grade fenitrothion.

1998

European eel (Anguilla anguilla) were exposed to sublethal fenitrothion concentrations in a continuous flow-through system for 4 days. Plasma acetylcholinesterase (AChE) activity was evaluated after 2, 8, 12, 24, 32, 48, 56, 72 and 96 h pesticide exposure. AChE activity in the plasma of the eel decreased as concentration of fenitrothion increased. Pesticide induced significant inhibitory effects on the AChE activity of A. anguilla ranging from 51% inhibition at sublethal concentration of 0.02 ppm to 57% inhibition at sublethal concentration of 0.04 ppm. Eel were exposed to both fenitrothion concentrations for 96 h and then allowed a period of recovery in pesticide-free water. Following 1 we…

medicine.medical_specialtyInsecticidesTime FactorsAchéImmunologyFenitrothionToxicologychemistry.chemical_compoundIn vivoInternal medicinemedicineAnimalsPharmacologychemistry.chemical_classificationDose-Response Relationship DrugFenitrothionPesticideAnguillaAcetylcholinesteraselanguage.human_languageEnzymeEndocrinologychemistryToxicitylanguageTechnical gradeAcetylcholinesteraseCholinesterase InhibitorsComparative biochemistry and physiology. Part C, Pharmacology, toxicologyendocrinology
researchProduct

Liver energy metabolism of Anguilla anguilla after exposure to fenitrothion.

1998

This paper deals with the effect of fenitrothion (0.04 mg/liter) on the energy metabolism of the European eel, Anguilla anguilla, and its recovery from intoxication. Various parameters such as glycogen, lactate, proteins, total lipids, and glucose in eel liver and blood were analyzed after 2, 8, 12, 24, 32, 48, 56, 72, and 96 h of fenitrothion exposure. Subsequently, the fish were allowed recovery periods of 8, 12, 24, 48, 72, 96, 144, and 192 h in clean water, and the same parameters were evaluated. Liver glycogen and lipid contents decreased significantly during the exposure, while blood glucose levels increased markedly. Liver and blood lactate values increased during pesticide exposure,…

medicine.medical_specialtyInsecticidesTime FactorsHealth Toxicology and MutagenesisFenitrothionchemistry.chemical_compoundAnguillidaeInternal medicinemedicineAnimalsPollutantGlycogenbiologyPublic Health Environmental and Occupational HealthLiterGeneral MedicineMetabolismFenitrothionPesticidebiology.organism_classificationAnguillaLipid MetabolismPollutionEndocrinologychemistryLiverToxicityEnergy MetabolismWater Pollutants ChemicalEcotoxicology and environmental safety
researchProduct

Characteristics of mucocutaneous vascular malformations drawn from a decade of a multidisciplinary committee experience.

2021

Vascular malformations (VM) are congenital, benign, and relatively frequent lesions. Scant data have been published about the epidemiology, clinical presentation, and treatment of VM from a dermatologist's perspective. The substantial differences between subtypes, broad range of specialists consulted and confusing nomenclature used over previous years may hamper a correct diagnosis. The main objective of this study is to describe VM epidemiology. As a secondary endpoint we evaluate clinical characteristics, clinical-radiological correlation and treatment approaches. We carried out an observational, descriptive, retrospective study. Cases presented to the multidisciplinary committee of our h…

medicine.medical_specialtyLymphatic Abnormalitiesbusiness.industryVascular MalformationsGeneral surgeryMedical recordmedicine.medical_treatmentMucocutaneous zoneRetrospective cohort studyDermatologyGeneral MedicineVeinsMultidisciplinary approachEpidemiologySclerotherapymedicineSclerotherapyHumansObservational studyCorPresentation (obstetrics)businessRetrospective Studies
researchProduct

Octaplex in routine clinical use for prophylaxis and therapy of bleeding in patients with prothrombin complex factor deficiency

2007

Octaplex is a new prothrombin complex concentrate that is indicated for treatment or perioperative prophylaxis of bleeding in patients with deficiency of the prothrombin complex coagulation factors, such as deficiency caused by treatment with vitamin K antagonists or by liver failure, when rapid correction of bleeding is required. The study was conducted to demonstrate both prevention of bleeding and achievement of haemostasis in acute bleeding and to obtain further information about the safety of administration of Octaplex.

medicine.medical_specialtyPediatricsbusiness.industryLiver failurePerioperativeAcute bleedingVitamin kCritical Care and Intensive Care MedicineProthrombin complex concentrateGastroenterologyCoagulationInternal medicinePoster PresentationmedicineIn patientbusinessPROTHROMBIN COMPLEXmedicine.drugCritical Care
researchProduct

Craniofacial venous malformations treated by percutaneous sclerotherapy using polidocanol: a single-center experience.

2018

Background Percutaneous therapy with various sclerosants is an established treatment of venous malformations in general. We investigated the safety and effectiveness of polidocanol in the craniofacial region. Purpose To present and evaluate our subjective and objective mid- and long-term results of patients with craniofacial venous malformations (CFVM) after percutaneous sclerotherapy using polidocanol. Material and Methods Twenty patients with CFVM treated by percutaneous sclerotherapy were followed up and asked to fill in a questionnaire comparing levels of the following CFVM-related symptoms before and after treatment: pain; functional impairment; cosmetic deformities; and impairment in …

medicine.medical_specialtyPercutaneousVascular Malformationsmedicine.medical_treatmentPolidocanol030204 cardiovascular system & hematologySingle Center030218 nuclear medicine & medical imagingPolidocanol03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesSclerotherapymedicineSclerotherapyHumansRadiology Nuclear Medicine and imagingCraniofacialRetrospective StudiesRadiological and Ultrasound Technologybusiness.industryHead neckGeneral MedicineSclerosing SolutionsSurgeryTreatment OutcomeFacebusinessNeckmedicine.drugActa radiologica (Stockholm, Sweden : 1987)
researchProduct

Autonomic nervous control of the urinary bladder

2013

The autonomic nervous system plays an important role in the regulation of the urinary bladder function. Under physiological circumstances, noradrenaline, acting mainly on β(3) -adrenoceptors in the detrusor and on α(1) (A) -adrenoceptors in the bladder outflow tract, promotes urine storage, whereas neuronally released acetylcholine acting mainly on M(3) receptors promotes bladder emptying. Under pathophysiological conditions, however, this system may change in several ways. Firstly, there may be plasticity at the levels of innervation and receptor expression and function. Secondly, non-neuronal acetylcholine synthesis and release from the urothelium may occur during the storage phase, leadi…

medicine.medical_specialtyPhysiologyReceptor expressionUrinary Bladder030232 urology & nephrologyAdrenergicBiologyurologic and male genital diseasesAutonomic Nervous System03 medical and health sciences0302 clinical medicineInternal medicineMuscarinic acetylcholine receptorReceptors Adrenergic betamedicineAnimalsHumansUrotheliumUrinary bladderNeuronal PlasticityUrinary Bladder DiseasesMuscarinic acetylcholine receptor M3Receptors Muscarinicfemale genital diseases and pregnancy complicationsAutonomic nervous systemmedicine.anatomical_structureEndocrinology030217 neurology & neurosurgeryAcetylcholinemedicine.drugActa Physiologica
researchProduct

Neuromuscular electrical stimulation: a new therapeutic option for chronic diseases based on contraction-induced myokine secretion

2019

Myokines are peptides known to modulate brain neuroplasticity, adipocyte metabolism, bone mineralization, endothelium repair and cell growth arrest in colon and breast cancer, among other processes. Repeated skeletal muscle contraction induces the production and secretion of myokines, which have a wide range of functions in different tissues and organs. This new role of skeletal muscle as a secretory organ means skeletal muscle contraction could be a key player in the prevention and/or management of chronic disease. However, some individuals are not capable of optimal physical exercise in terms of adequate duration, intensity or muscles involved, and therefore they may be virtually deprived…

medicine.medical_specialtyPhysiologyStimulationPhysical exerciseReviewskeletal muscle contractionTranscutaneous electrical nerve stimulationcytokines; electrotherapy; physical exercise; skeletal muscle contraction; transcutaneous electrical nerve stimulationlcsh:Physiologylaw.inventionMuscle hypertrophyParacrine signallingtranscutaneous electrical nerve stimulationlawphysical exerciseInternal medicinePhysiology (medical)MyokinemedicineAutocrine signallinglcsh:QP1-981business.industrySkeletal muscleDeporteEjercicio físicocytokinesElectroterapiaEndocrinologymedicine.anatomical_structureTerapiaelectrotherapyElectricidadbusiness
researchProduct

Comparación de las frecuencias de los alelos factor V Leiden (G1691A) y protrombina-G20210A entre pacientes con trombosis venosa profunda y población…

2006

Background: Factor V leiden and the -G20210A variant of prothrombin gene are associated to a higher risk of deep venous thrombosis. Aim: To assess the frequency of factor V Leiden (G1691A) and prothrombin -G20210A alleles in patients with deep venous thrombosis (DVT) and in the general population from Spain. Material and methods: Factor V Leiden (g1691a) and prothrombin-g20210a alleles were genotyped in 493 individuals from the Spanish general populations and in 131 patients with DVT. The presence of DVT was confirmed by phlebography. Allelic frequencies and the DVT risk associated with these variants were estimated. Results: Allelic frequencies for the factor V Leiden (G1691A) allele were …

medicine.medical_specialtyPopulationGastroenterologyInternal medicinehemic and lymphatic diseasesGenotypeG20210AVenous thrombosismedicineFactor V Leidencardiovascular diseasesAlleleeducationAlleleseducation.field_of_studyFactor V Leidenbusiness.industryGeneral MedicineOdds ratiomedicine.diseaseConfidence intervalSurgeryVenous thrombosisProthrombin geneProthrombin G20210Abusiness
researchProduct